||**Somali Health Exchange**<br>**1**|**Somali Health Exchange**<br>**1**|**Somali Health Exchange**<br>**1**|**191571**||
|---|---|---|---|---|---|
||**For the period**<br>**from**|Period start date<br>**1-Apr-24**|**To**|Period end date<br>**31-Mar-25**||
|||||||
|**Section A Income and Expenditure**||||||
|**A1 Income**<br>Donations 01 April 2024 to 31 March 2025<br>**306.80**<br>Interest 01 April 2024 to 31 March 2025<br>**3.92**<br>**310.72**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                  310.72**<br>**A3 Expenditure**<br>**-**<br>**_Sub total_                                -**<br>n/a<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                            -**<br>**_Net of receipts/(payments)_                  310.72**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**1,210.70**<br>**_Cash funds this year end_               1,521.42**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases,(see table)**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**307**<br>**4**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**311**<br>**-**<br>**-**<br>**-**<br>**311**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**311**<br>**-**<br>**1,211**<br>**1,521**|**Last year**<br>**to the nearest £**|
||||**-**<br>**-**<br>**-**|**307**||
|||||**4**||
|||||**-**|**-**|
|||||**-**||
|||||**-**||
|||||**-**||
|||||**-**||
|||||**311**|**-**|
|||||||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**|**-**|
|||||**-**|**-**|
||||**-**|**311**|**-**|
|||||||
||||**-**<br>**-**<br>**-**<br>**-**|**-**|**-**|
|||||**-**|**-**|
|||||**-**||
|||||**-**||
|||||**-**||
|||||**-**||
|||||**-**||
|||||**-**|**-**|
|||||**-**|**-**|
|||||||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**||
|||||**-**|**-**|
|||||||
||||**-**|**-**|**-**|
|||||||
|||**-**|**-**<br>**-**<br>**-**<br>**-**|**311**|**-**|
|||**-**||**-**|**-**|
|||**-**||**1,211**|**-**|
|||**-**||**1,521**|**-**|





|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>n/a<br>**Details**<br>n/a<br>**Details**<br>n/a<br>**Details**<br>n/a<br>**Details**<br>n/a<br>Signature<br>A. Saleh<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Amal Saleh<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
||||Date of<br>approval|
||A. Saleh|Amal Saleh|22-Mar-24|
|||||



